April Armstrong

University of California, Davis United States of America

Dr. April W. Armstrong is Director of the Clinical Research Unit and Teledermatology Program at the Department of Dermatology. Dr. Armstrong completed training at Harvard Dermatology Residency Program and Harvard School of Public Health. While at Harvard, she also completed a one-year dermatopathology research fellowship with Dr. Martin Mihm focusing on the prognostic significance of tumor infiltrating lymphocytes in melanoma. Dr. Armstrong is actively engaged in clinical research as well as medical education, with an emphasis on telehealth and chronic inflammatory dermatoses. She believes that good clinical practice needs to be rooted in evidence-based medicine, and rigorous research forms the foundation for innovations in dermatology. Dr. Armstrong’s research is supported by the Dermatology Foundation, National Psoriasis Foundation, California Healthcare Foundation, Agency for Healthcare Research and Quality, and the National Institute of Health.

1books edited

2chapters authored

Latest work with IntechOpen by April Armstrong

This book titled Advances in Malignant Melanoma - Clinical and Research Perspectives represents an international effort to highlight advances in our understanding of malignant melanoma from both clinical and research perspectives. The authors for this book consist of an international group of recognized leaders in melanoma research and patient care, and they share their unique perspectives regarding melanoma epidemiology, risk factors, diagnostic and prognostic tools, phenotypes, treatment, and future research directions. The book is divide into four sections: (1) Epidemiology and Risk Factors of Melanoma, (2) Clinical Phenotypes of Melanoma, (3) Investigational Treatments for Melanoma and Pigmentary Disorders, and (4) Advances in Melanoma Translational Research. This book does not attempt to exhaustively cover all aspects of the aforementioned topics. Rather, it is a compilation of our authors' pearls and unique perspectives on the relevant advances in melanoma during the recent years.

Go to the book